About NBRIC

National Biomedical Resource Indigenisation Consortium NBRIC was constituted by the Department of Biotechnology, Ministry of Science and Technology, Government of India as a Public Private Partnership to drive indigenous innovation focused on developing reagents, diagnostics, vaccines and therapeutics for COVID19.

Hosted and led by the Centre for Cellular and Molecular Platforms – C-CAMP, NBRIC aims to be a nation-wide collaborative platform for convergence of research, product resources and services towards developing reagents, diagnostics, vaccines and therapeutics across India.

NBRIC is a ‘A Make in India’ initiative for Biomedical research and innovative products, towards promoting import substitution and exports.

NBRIC Tweets -

Objectives

  • Identify providers/manufacturing enterprises of crucial bio-medical resources
  • Assess their current capabilities, capacities and requirements
  • Support them by creating a enabling environment and connecting with policy makers and other stakeholders from public and private sectors
  • Be the gateway for funding from DBT, BIRAC and DST for development or scaling

Mission

  • To be a nation-wide platform for convergence of research, product resources, and services towards developing reagents, diagnostics, vaccines, and therapeutics across India for COVID-19 response
  • A Make in India initiative for Biomedical research and innovative products, towards import substitution and export

 

ABOUT – C-CAMP

Centre for Cellular and Molecular Platforms – C-CAMP (www.ccamp.res.in), a Department of Biotechnology DBT, Government of India initiative, is one of the most exciting centers for technology-based innovation and entrepreneurship in India in the field of life sciences. C-CAMP was established with the aim of enabling cutting-edge bio-science research and entrepreneurship, by: i) developing and making available state-of-the-art technologies and providing training on these technologies to academia and industry, ii) building a thriving ecosystem to stimulate innovation and promote bio-tech entrepreneurship.

When the Government of India announced the lockdown for the COVID-19 pandemic, C-CAMP launched the C-CAMP COVID-19 Innovations Deployment Accelerator, to identify and help accelerate near deployment ready solutions that can help fight the COVID 19 infections. In 31 days and 1100 applications later, 31 solutions were identified, with 17 of these already in the field.